Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fajgenbaum

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Plos Medicine|March 12, 2026
Quantify unmet medical need across the disease landscape - A large language model-based methodologyElliott W Sharp, Nicholas Fragola, Charlotte Blewitt, et al.
Faculty Reviews|July 11, 2022
Anti-type I interferon antibodies as a cause of severe COVID-19David C Fajgenbaum, Adrian C Hayday, Angela J Rogers, et al.
Blood Advances|July 6, 2022
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman diseaseFrits van Rhee, Adam Rosenthal, Karan Kanhai, et al.
The Lancet. Haematology|June 30, 2022
Idiopathic multicentric Castleman disease with arteriolar endotheliopathy and secondary haemophagocytosisChristine M Campbell, Daniel R Owen, Amanallah Montazeripouragha, et al.
Orphanet Journal of Rare Diseases|October 28, 2022
Sharing is caring: a call for a new era of rare disease research and developmentNathan Denton, Andrew E Mulberg, Monique Molloy, et al.
Hematological Oncology|February 1, 2022
Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature reviewElizaveta Belyaeva, Ayelet Rubenstein, Sheila K Pierson, et al.
Orphanet Journal of Rare Diseases|January 23, 2023
Correction to: Sharing is caring: a call for a new era of rare disease research and developmentNathan Denton, Andrew E Mulberg, Monique Molloy, et al.
Vaccines|October 27, 2022
Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 VaccineChristian Hoffmann, Thomas Wechselberger, Heinz Drexel, et al.
Scientific Reports|January 11, 2025
No evidence for active viral infection in unicentric and idiopathic multicentric Castleman disease by Viral-Track analysisIra Miller, Melanie D Mumau, Saishravan Shyamsundar, et al.
American Journal of Hematology|October 23, 2023
Siltuximab administration results in spurious IL-6 elevation in peripheral bloodNatalie A Mango, Sheila K Pierson, Mateo Sarmiento Bustamante, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Plos Medicine|March 12, 2026
Quantify unmet medical need across the disease landscape - A large language model-based methodologyElliott W Sharp, Nicholas Fragola, Charlotte Blewitt, et al.
Faculty Reviews|July 11, 2022
Anti-type I interferon antibodies as a cause of severe COVID-19David C Fajgenbaum, Adrian C Hayday, Angela J Rogers, et al.
Blood Advances|July 6, 2022
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman diseaseFrits van Rhee, Adam Rosenthal, Karan Kanhai, et al.
The Lancet. Haematology|June 30, 2022
Idiopathic multicentric Castleman disease with arteriolar endotheliopathy and secondary haemophagocytosisChristine M Campbell, Daniel R Owen, Amanallah Montazeripouragha, et al.
Orphanet Journal of Rare Diseases|October 28, 2022
Sharing is caring: a call for a new era of rare disease research and developmentNathan Denton, Andrew E Mulberg, Monique Molloy, et al.
Hematological Oncology|February 1, 2022
Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature reviewElizaveta Belyaeva, Ayelet Rubenstein, Sheila K Pierson, et al.
Orphanet Journal of Rare Diseases|January 23, 2023
Correction to: Sharing is caring: a call for a new era of rare disease research and developmentNathan Denton, Andrew E Mulberg, Monique Molloy, et al.
Vaccines|October 27, 2022
Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 VaccineChristian Hoffmann, Thomas Wechselberger, Heinz Drexel, et al.
Scientific Reports|January 11, 2025
No evidence for active viral infection in unicentric and idiopathic multicentric Castleman disease by Viral-Track analysisIra Miller, Melanie D Mumau, Saishravan Shyamsundar, et al.
American Journal of Hematology|October 23, 2023
Siltuximab administration results in spurious IL-6 elevation in peripheral bloodNatalie A Mango, Sheila K Pierson, Mateo Sarmiento Bustamante, et al.
Pageof 12